ArticleSLAS discovery : advancing life sciences R & D2025

A novel high-throughput screening platform to identify inhibitors of DNAJB1-PRKACA-driven transcriptional activity in fibrolamellar carcinoma.

Nihal Bharath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.